Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2526
Materion
MTRN
$5.66B
| $984K | ﹤0.01% |
12,400
-19,900
| -62% | -$1.57M |
2017 Q4
30 quarters
|
|
2527
Invesco CurrencyShares Swiss Franc Trust
FXF
$369M
| $984K | ﹤0.01% |
+8,800
| New | +$945K |
2025 Q2
0 quarters
|
|
2528
Zevia
ZVIA
$85.1M
| $979K | ﹤0.01% |
304,126
+47,400
| +18% | +$125K |
2023 Q3
7 quarters
|
|
2529
Natural Alternatives International
NAII
$7.83M
| $976K | ﹤0.01% |
297,656
-6,500
| -2% | -$20.7K |
2013 Q2
48 quarters
|
|
2530
iHeartMedia
IHRT
$300M
| $976K | ﹤0.01% |
554,600
+58,400
| +12% | +$77.8K |
2021 Q2
16 quarters
|
|
2531
Primoris Services
PRIM
$4.43B
| $974K | ﹤0.01% |
+12,491
| New | +$847K |
2025 Q2
0 quarters
|
|
2532
Palmer Square Capital BDC
PSBD
$297M
| $973K | ﹤0.01% |
69,700
-19,700
| -22% | -$266K |
2024 Q2
4 quarters
|
|
2533
First Commonwealth Financial
FCF
$2.04B
| $972K | ﹤0.01% |
59,900
+30,200
| +102% | +$466K |
2024 Q4
2 quarters
|
|
2534
Matthews International
MATW
$582M
| $972K | ﹤0.01% |
40,653
-9,200
| -18% | -$194K |
2025 Q1
1 quarter
|
|
2535
Bowman Consulting
BWMN
$710M
| $969K | ﹤0.01% |
+33,700
| New | +$831K |
2025 Q2
0 quarters
|
|
2536
CBRE Group
CBRE
$37.8B
| $967K | ﹤0.01% |
+6,900
| New | +$873K |
2025 Q2
0 quarters
|
|
2537
DELISTED
Civitas Resources
CIVI
| $966K | ﹤0.01% |
35,104
-98,303
| -74% | -$2.85M |
2025 Q1
1 quarter
|
|
2538
DELISTED
Blue Foundry Bancorp
BLFY
| $966K | ﹤0.01% |
100,890
+23,290
| +30% | +$216K |
2022 Q2
12 quarters
|
|
2539
Freedom Holding
FRHC
$10.6B
| $964K | ﹤0.01% |
+6,600
| New | +$974K |
2025 Q2
0 quarters
|
|
2540
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.48B
| $964K | ﹤0.01% |
7,800
-8,000
| -51% | -$941K |
2024 Q4
2 quarters
|
|
2541
Ardent Health
ARDT
$1.61B
| $963K | ﹤0.01% |
70,500
+24,800
| +54% | +$334K |
2025 Q1
1 quarter
|
|
2542
BKV Corp
BKV
$2.64B
| $960K | ﹤0.01% |
39,800
-65,200
| -62% | -$1.35M |
2024 Q4
2 quarters
|
|
2543
Invesco S&P 500 Revenue ETF
RWL
$10B
| $959K | ﹤0.01% |
+9,200
| New | +$910K |
2025 Q2
0 quarters
|
|
2544
ACM Research
ACMR
$4.79B
| $958K | ﹤0.01% |
+37,000
| New | +$832K |
2025 Q2
0 quarters
|
|
2545
electroCore
ECOR
$82.8M
| $954K | ﹤0.01% |
180,686
+2,261
| +1% | +$12.9K |
2020 Q4
18 quarters
|
|
2546
Everus Construction Group
ECG
$6.14B
| $953K | ﹤0.01% |
15,000
+7,700
| +105% | +$390K |
2025 Q1
1 quarter
|
|
2547
Metropolitan Bank Holding Corp
MCB
$1.09B
| $952K | ﹤0.01% |
+13,600
| New | +$842K |
2025 Q2
0 quarters
|
|
2548
Putnam Focused Large Cap Value ETF
PVAL
$14.8B
| $945K | ﹤0.01% |
+23,500
| New | +$886K |
2025 Q2
0 quarters
|
|
2549
NLI Holdings
NL
$341M
| $943K | ﹤0.01% |
147,414
-1,900
| -1% | -$14.3K |
2014 Q4
42 quarters
|
|
2550
Erasca
ERAS
$5.4B
| $943K | ﹤0.01% |
742,500
-214,007
| -22% | -$286K |
2022 Q4
10 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.